Boston Scientific accounts are for healthcare professionals only.
Join our events
Lunch Symposium
Boston Scientific: Advancing Science for the Future of Interventional Pain Care
Discover the breakthrough innovations and evidence that are shaping the next era of interventional pain therapies.
Friday, January 23 from 11:30am – 1:00pm
Augustus III-IV
Caesars Palace
Presented by Manny Gage, MD,* David Lee, MD,* Ramo Naidu, MD,* and Kiran Patel, MD*
Moderated by Michael Esposito, MD*
Educational Event
Advancing Innovation: An Evening with Boston Scientific
Join your peers and industry leaders for insightful conversations on emerging technologies that are shaping the future of interventional pain care.
Friday, January 23 from 6:30pm – 8:00pm
Vista Lounge
Caesars Palace
Featuring Ajay Antony, MD,* Brian Durkin, DO,* Martin Ferrillo, MO,* and Morgan Pollard, MD*
Clinical and scientific data presentations
Pain management
Oral Presentations
Multidimensional Outcomes of SCS: A Prospective Multicenter Observational Study
Addressing Loss-of-Efficacy in Long-Term, Permanently-Implanted SCS Patients: Therapy Salvage Using Standardized Connections or Adapters
Real-World Long-term Outcomes in a Chronic Pain Patient European Cohort Undergoing a Single-Stage SCS-Implantation Procedure
Digital Pain Mapping Post-Rescue Conversion in Spinal Cord Stimulation Using Wave-Up Software
Targeted Radiofrequency Ablation Techniques for Specific Low Back Pain Syndromes: Real-World Observational Study Outcomes
Radiofrequency Ablation Outcomes for Chronic Low Back Pain Using a New Cannula with Deployment Design
Holistic Spinal Cord Stimulation Approach Treating Painful Diabetic Peripheral Neuropathy: Outcomes from the INSPIRE Study
Poster Presentations
Friday, January 23 from 5:00pm - 6:30pm
Radiofrequency Ablation Outcomes for Chronic Low Back Pain Using a New Cannula with Deployment Design
Bayerl et al.
Addressing Loss-of-Efficacy in Long-Term, Permanently-Implanted SCS Patients: Therapy Salvage Using Standardized Connections or Adapters
Hussain et al.
Targeted Radiofrequency Ablation Techniques for Specific Low Back Pain Syndromes: Real-World Observational Study Outcomes
Kyriakopoulos et al.
Real-World Long-term Outcomes in a Chronic Pain Patient European Cohort Undergoing a Single-Stage SCS-Implantation Procedure
Paz-Solis et al.
Digital Pain Mapping Post-Rescue Conversion in Spinal Cord Stimulation using Wave-Up Software
Rigoard et al.
Holistic Spinal Cord Stimulation Approach Treating Painful Diabetic Peripheral Neuropathy: Outcomes from the INSPIRE Study
Rizea et al.
Multidimensional Outcomes of SCS: A Prospective Multicenter Observational Study
Thomson et al.
Deep Brain Stimulation
Oral Presentations
Real-World Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control - USA Experience
Real-World Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients
Characterizing Time to Depletion in Multiple-Independent Current-Controlled Rechargeable Implantable Pulse Generators for Deep Brain Stimulation
Poster Presentations
Friday, January 23 from 5:00pm - 6:30pm
Real-World Clinical and Safety Outcomes from a Prospective, Multicenter DBS Registry of Essential Tremor Patients
Deuschl/Shuurman et al.
Characterizing Time to Depletion in Multiple-Independent Current-Control Rechargeable Implantable Pulse Generators for Deep Brain Stimulation
Niketeghad et al.
Real-World Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control - USA Experience
Okun et al.
1. Gage E., et al. Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-Perception Therapy SCS [Abstract] NANS 2023 Annual Meeting, Jan 12-15, 2023.
2. Anitescu M., et al. Utilizing SCS Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy (FAST): Prospective, Multicenter, Long-Term Outcomes [Abstract] NANS 2025 Annual Meeting, Jan 30-Feb1, 2025.
3. Metzger C, Hammond B, Ferro R, North J, Pyles S, Kranenburg A, Washabaugh E, Goldberg E. Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States. Expert Rev Med Devices. 2025 Jan-Feb;22(2):155-164.
4. Bayerl S, Paz-Solis J, Matis G, et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. JCM. 2024;13(22):6999
5. Ferro R, North J, Kranenburg A, et al. Automated neural dosing for fast-acting subperception therapy: sustained spinal cord stimulation outcomes from a multicenter study. Pain Ther. 2025;14(4):1417-1429.
6. Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. doi.org/10.1007/s00586-020-06448-x
*The noted individual(s) serves as a consultant to Boston Scientific and is compensated for services provided under a consulting agreement.
U.S. Federal Government Employees – U.S. Federal Government Employees may be required to obtain approval from their agency’s or institution’s ethics officer or ethics committee or from a supervisor to attend this program. For more details, please contact your ethics officer or supervisor.
Vermont-Licensed HCPs – Vermont law prohibits Boston Scientific from providing any food, meals or refreshments at no charge to health care professionals licensed by and regularly practicing in Vermont. Accordingly, health care professionals licensed by and regularly practicing in Vermont are requested not to partake in any of the food, meals or refreshments offered at this event.
All U.S. Physicians – The U.S. Physician Payment Sunshine Act requires all pharmaceutical, biologics and medical device companies to disclose annually to the U.S. government payments and transfers of value provided to U.S. physicians and teaching hospitals. This includes the value of meals and refreshments provided to U.S. physicians in connection with attending Boston Scientific educational programs.
Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population.
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.
View Boston Scientific Spinal Cord Stimulator System Indications, Safety, and Warnings
View Boston Scientific Radiofrequency Ablation Indications, Safety, and Warnings
View Boston Scientific Deep Brain System Indications, Safety, and Warnings